Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
Black
White
cell-free DNA
comprehensive genomic profiling
prostate cancer
Journal
The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837
Informations de publication
Date de publication:
01 10 2022
01 10 2022
Historique:
received:
20
01
2022
accepted:
11
07
2022
pubmed:
30
8
2022
medline:
5
10
2022
entrez:
29
8
2022
Statut:
ppublish
Résumé
Advanced prostate cancer (aPC) in Black men was reported to present with aggressive features and to be associated with poor prognosis. Herein, we compared the cell-free DNA (cfDNA) genomic landscape of aPC in Black vs White men. Patients (pts) with aPC from 6 academic institutions and available cfDNA comprehensive genomic profiling (CGP) were included. Association between mutated genes and race was evaluated using Barnard's test and a Probabilistic Graphical Model (PGM) machine learning approach. Analysis included 743 aPC pts (217 Black, 526 White) with available cfDNA CGP. The frequency of alterations in the androgen receptor gene was significantly higher in Black vs White men (55.3% vs 35% respectively, P < .001). Additionally, alterations in EGFR, MYC, FGFR1, and CTNNB1 were present at higher frequencies in Black men. PGM analysis and Barnard's test were concordant. Findings from the largest cohort of Black men with aPC undergoing cfDNA CGP may guide further drug development in these men.
Identifiants
pubmed: 36036607
pii: 6678487
doi: 10.1093/oncolo/oyac176
pmc: PMC9526493
doi:
Substances chimiques
Cell-Free Nucleic Acids
0
Receptors, Androgen
0
ErbB Receptors
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e815-e818Informations de copyright
© The Author(s) 2022. Published by Oxford University Press.
Références
J Clin Oncol. 2019 Feb 10;37(5):403-410
pubmed: 30576268
Prostate Cancer Prostatic Dis. 2020 Sep;23(3):517-526
pubmed: 32111923
Cancer Rep (Hoboken). 2021 Oct;4(5):e1340
pubmed: 33599076
EBioMedicine. 2017 Apr;18:83-93
pubmed: 28412251
Clin Cancer Res. 2022 Jan 15;28(2):318-326
pubmed: 34667026
Oncologist. 2021 Sep;26(9):751-760
pubmed: 34157173
N Engl J Med. 2020 May 28;382(22):2091-2102
pubmed: 32343890